×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Iovance Biotherapeutics Inc. (IOVA) NASDAQ

$14.82 0.72 (5.11%)

Market Cap: $4.14B

As of 03/28/24 04:00 PM EDT. Market closed.

(IOVA)

Iovance Biotherapeutics Inc. (IOVA)
NASDAQ

$14.82
0.72 (5.11%)

Market Cap: $4.14B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr. steven a. rosenberg at the national cancer institute (nci). in phase 2 clinical trials conducted at the nci, 56% and 24% of patients treated with this ... read more

iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr. steven a. rosenberg at the national cancer institute (nci). in phase 2 clinical trials conducted at the nci, 56% and 24% of patients treated with this technology were reported by nci to have achieved objective and complete response criteria, respectively. our lead product candidate is an autologous, ready-to-infuse cell therapy, that has demonstrated distinctive efficacy in the treatment of metastatic melanoma. in addition to metastatic melanoma, carcinoma of the head and neck and cervical cancer our til therapy technology is potentially applicable to many other tumor types, including ovarian, breast, bladder, colorectal and other cancers. as we continue advancing our current clinical programs through the introduction of manufacturing and logistical read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.39M
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.39M
Address
.
PRICE CHART FOR IOVANCE BIOTHERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.17
Previous Close
$14.10
Days Range
$14.10 - $15.18
52 week range
$3.21 - $18.33
Volume
6,187,850
Avg. Volume (30 days)
8,324,909
Market Cap
$4.14B
Dividend Yield
-
P/E
-
Shares Outstanding
279,307,043
Open
$14.17
Previous Close
$14.10
Days Range
$14.10 - $15.18
52 week range
$3.21 - $18.33
Volume
6,187,850
Avg. Volume (30 days)
8,324,909
Market Cap
$4.14B
Dividend Yield
-
P/E
-
Shares Outstanding
279,307,043
FINANCIAL STATEMENTS FOR IOVANCE BIOTHERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IOVANCE BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerMar 04, 2024 Option Exercise$16.968,053136,57941,177Mar 06, 2024, 06:20 PM
Vogt Frederick GInterim CEO & General CounselMar 04, 2024 Option Exercise$16.9611,449194,175129,351Mar 06, 2024, 06:19 PM
BILINSKY IGORChief Operating OfficerMar 04, 2024 Option Exercise$16.967,287123,58836,641Mar 06, 2024, 06:17 PM
MCPEAK MERRILL ADirectorFeb 20, 2024 Buy$9.15250,0002,287,500320,150Feb 20, 2024, 07:52 PM
Dukes Iain D.DirectorFeb 20, 2024 Buy$9.1532,000292,80054,000Feb 20, 2024, 04:21 PM
Rothbaum Wayne P.DirectorFeb 20, 2024 Buy$9.155,000,00045,749,99828,067,333Feb 20, 2024, 04:11 PM
Vogt Frederick GInterim CEO & General CounselJan 16, 2024 Option Exercise$8.376,53054,65699,138Jan 18, 2024, 06:09 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJan 16, 2024 Option Exercise$8.371,57713,19933,607Jan 18, 2024, 06:09 PM
BILINSKY IGORChief Operating OfficerJan 16, 2024 Option Exercise$8.371,57713,19929,867Jan 18, 2024, 06:07 PM
Vogt Frederick GInterim CEO & General CounselOct 16, 2023 Option Exercise$3.578,85131,59884,834Oct 18, 2023, 08:05 PM
BILINSKY IGORChief Operating OfficerOct 16, 2023 Option Exercise$3.571,3954,98028,631Oct 18, 2023, 08:04 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOct 16, 2023 Option Exercise$3.571,3954,98032,371Oct 18, 2023, 08:03 PM
MCPEAK MERRILL ADirectorSep 18, 2023 Buy$5.5610,00055,600248,633Sep 19, 2023, 04:30 PM
Rothbaum Wayne P.DirectorSep 15, 2023 Buy$5.305,000,00026,500,00123,067,333Sep 15, 2023, 06:12 PM
Vogt Frederick GInterim CEO & General CounselJul 14, 2023 Option Exercise$7.768,85168,68472,850Jul 17, 2023, 06:22 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJul 14, 2023 Option Exercise$7.761,39510,82530,953Jul 17, 2023, 06:22 PM
BILINSKY IGORChief Operating OfficerJul 14, 2023 Option Exercise$7.761,39510,82527,213Jul 17, 2023, 06:21 PM
Vogt Frederick GInterim CEO & General CounselApr 14, 2023 Option Exercise$5.648,85149,92060,867Apr 18, 2023, 05:50 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerApr 14, 2023 Option Exercise$5.641,3957,86829,535Apr 18, 2023, 05:49 PM
BILINSKY IGORChief Operating OfficerApr 14, 2023 Option Exercise$5.641,3957,86825,795Apr 18, 2023, 05:48 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJan 17, 2023 Option Exercise$6.434,67830,08028,118Jan 19, 2023, 04:52 PM
BILINSKY IGORChief Operating OfficerJan 17, 2023 Option Exercise$6.434,67130,03524,378Jan 19, 2023, 04:52 PM
Vogt Frederick GInterim CEO & General CounselJan 17, 2023 Option Exercise$6.4336,441234,31648,884Jan 19, 2023, 04:51 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJan 03, 2023 Option Exercise$6.1111,02367,35121,548Jan 05, 2023, 08:57 PM
BILINSKY IGORChief Operating OfficerJan 03, 2023 Option Exercise$6.1110,55364,47917,801Jan 05, 2023, 08:45 PM
Bellemin Jean-MarcChief Financial OfficerJan 03, 2023 Option Exercise$6.1110,55364,47917,801Jan 05, 2023, 08:45 PM
MCPEAK MERRILL ADirectorDec 21, 2022 Buy$6.1510,00061,50070,150Dec 22, 2022, 04:06 PM
Rothbaum Wayne P.DirectorDec 02, 2022 Buy$6.5010,000,00065,000,00018,067,333Dec 02, 2022, 05:29 PM
MCPEAK MERRILL ADirectorNov 29, 2022 Buy$6.3110,00063,100238,633Nov 30, 2022, 04:17 PM
Vogt Frederick GInterim CEO & General CounselNov 28, 2022 Buy$5.981,0005,9802,000Nov 28, 2022, 09:46 PM
MCPEAK MERRILL ADirectorNov 28, 2022 Buy$6.1810,00061,800228,633Nov 28, 2022, 09:44 PM
Dukes Iain D.DirectorNov 23, 2022 Buy$6.1010,00061,00022,000Nov 28, 2022, 09:43 PM
MCPEAK MERRILL ADirectorAug 23, 2022 Option Exercise$5.6540,000226,00060,150Aug 25, 2022, 04:15 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJun 14, 2022 Option Exercise$7.736,80952,63412,881Jun 16, 2022, 05:04 PM
Bellemin Jean-MarcChief Financial OfficerJun 14, 2022 Option Exercise$7.739,34672,2459,504Jun 16, 2022, 05:03 PM
BILINSKY IGORChief Operating OfficerJun 14, 2022 Option Exercise$7.739,34672,2459,504Jun 16, 2022, 05:03 PM
MCPEAK MERRILL ADirectorMay 31, 2022 Buy$6.8010,00068,000218,633Jun 02, 2022, 08:03 PM
MCPEAK MERRILL ADirectorMay 31, 2022 Buy$6.8410,00068,40020,150Jun 02, 2022, 08:03 PM
Maynard Ryan DDirectorMay 31, 2022 Buy$6.747,50050,5877,500Jun 02, 2022, 08:02 PM
WEISER MICHAELDirectorMay 31, 2022 Buy$6.8010,00067,978112,632Jun 02, 2022, 08:01 PM
Vogt Frederick GInterim CEO & General CounselJun 01, 2022 Buy$6.441,0006,4401,000Jun 02, 2022, 08:00 PM
Rothbaum Wayne P.DirectorMay 31, 2022 Buy$6.77500,0003,384,5507,567,333Jun 02, 2022, 07:59 PM
Rothbaum Wayne P.DirectorJun 01, 2022 Buy$6.43500,0003,215,5008,067,333Jun 02, 2022, 07:59 PM
Fardis MariaPresident and CEOJun 01, 2020 Option Exercise$33.121,89462,729298,786Jun 02, 2020, 07:19 PM
Fardis MariaPresident and CEOMay 01, 2020 Option Exercise$32.001,89460,608300,680May 04, 2020, 09:01 PM
Fardis MariaPresident and CEOApr 01, 2020 Option Exercise$27.941,49441,742302,574Apr 03, 2020, 04:30 PM
Fardis MariaPresident and CEOMar 02, 2020 Option Exercise$35.991,32147,543304,068Mar 04, 2020, 05:00 PM
Fardis MariaPresident and CEOFeb 03, 2020 Option Exercise$22.541,30229,347305,389Feb 05, 2020, 04:31 PM
Fardis MariaPresident and CEOJan 02, 2020 Option Exercise$26.681,56241,674306,691Jan 06, 2020, 07:00 PM
Fardis MariaPresident and CEODec 02, 2019 Option Exercise$22.661,89442,918308,253Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEONov 01, 2019 Option Exercise$21.971,89441,611310,147Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEONov 01, 2017 Option Exercise$7.151,99414,257344,863Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJun 03, 2019 Option Exercise$18.041,32123,831318,187Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMay 01, 2018 Option Exercise$14.601,32119,287335,819Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEONov 01, 2018 Option Exercise$9.621,32112,708327,893Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOOct 01, 2017 Option Exercise$7.751,99315,446346,857Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMay 01, 2019 Option Exercise$11.141,32114,716319,508Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOApr 01, 2018 Option Exercise$16.901,32122,325337,140Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOOct 01, 2018 Option Exercise$11.121,32114,690329,214Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOSep 01, 2017 Option Exercise$6.001,99411,964348,850Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOApr 01, 2019 Option Exercise$9.781,32112,919320,829Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMar 01, 2018 Option Exercise$18.151,32123,976338,461Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOOct 01, 2019 Option Exercise$18.211,89434,490312,041Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOSep 04, 2018 Option Exercise$17.101,32122,589330,535Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOAug 01, 2017 Option Exercise$5.701,99311,360350,844Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMar 01, 2019 Option Exercise$10.771,29813,979322,150Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOFeb 01, 2018 Option Exercise$16.501,52525,163339,782Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOSep 03, 2019 Option Exercise$20.271,61032,635313,935Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOAug 01, 2018 Option Exercise$13.701,32118,098331,856Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJul 01, 2017 Option Exercise$7.351,99414,656352,837Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOFeb 01, 2019 Option Exercise$9.261,56214,464323,448Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJan 01, 2018 Option Exercise$8.001,56212,496341,307Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOAug 01, 2019 Option Exercise$25.171,32133,250315,545Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJul 01, 2018 Option Exercise$12.801,32116,909333,177Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJun 01, 2017 Option Exercise$5.45143,496782,053354,831Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJan 02, 2019 Option Exercise$9.451,56214,761325,010Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEODec 01, 2017 Option Exercise$8.801,99417,547342,869Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJul 01, 2019 Option Exercise$24.621,32132,523316,866Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJun 01, 2018 Option Exercise$14.551,32119,221334,498Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOApr 03, 2017 Option Exercise$7.1551,673369,462498,327Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEODec 01, 2018 Option Exercise$10.441,32113,791326,572Dec 04, 2019, 09:01 PM
Dukes Iain D.DirectorDec 18, 2018 Buy$8.6512,000103,79612,000Dec 20, 2018, 05:00 PM
MCPEAK MERRILL ADirectorDec 13, 2018 Buy$9.6310,00096,273456,583Dec 14, 2018, 05:00 PM
Rothbaum Wayne P.DirectorDec 06, 2018 Buy$9.86300,0002,958,0007,067,333Dec 07, 2018, 04:32 PM
Rothbaum Wayne P.DirectorDec 04, 2018 Buy$10.31921,0539,496,0576,767,333Dec 07, 2018, 04:32 PM
Hillsberg SanfordDirectorAug 25, 2016 Sale$8.7120,500178,612100,000Aug 26, 2016, 03:49 PM
Hillsberg SanfordDirectorAug 24, 2016 Sale$9.1033,500304,800120,500Aug 26, 2016, 03:49 PM
Hillsberg SanfordDirectorAug 22, 2016 Sale$9.1154,000491,740100,000Aug 24, 2016, 02:18 PM
HAWKINS ELMAPresident and CEOFeb 28, 2015 Option Exercise$8.9823,988215,412176,567Dec 30, 2015, 06:57 PM
Bender James G.Vice President, ManufacturingSep 30, 2015 Option Exercise$5.7611,27464,93888,726Dec 30, 2015, 03:00 PM
Hillsberg SanfordDirectorSep 04, 2015 Sale$6.8416,000109,440170,500Sep 09, 2015, 01:13 PM
Hillsberg SanfordDirectorSep 08, 2015 Sale$7.1316,500117,645154,000Sep 09, 2015, 01:13 PM
Hillsberg SanfordDirectorAug 03, 2015 Sale$8.1532,500264,875186,500Aug 04, 2015, 05:05 PM
Ayer Capital Management, LP10% OwnerMay 01, 2015 Sale$9.622,780,68226,752,3852,823,333May 08, 2015, 01:07 PM
Hillsberg SanfordDirectorMay 06, 2015 Sale$10.0050,000500,000219,000May 07, 2015, 05:49 PM
BRISTOL INVESTMENT FUND LTD10% OwnerNov 06, 2014 Sale$690000.00100,00069,000,000,0003,867,863Nov 07, 2014, 08:41 AM
Ayer Capital Management, LPDirectorMay 22, 2013 Option Exercise$0.05560,088,65027,444,343560,401,150Jul 23, 2014, 06:38 AM
MCPEAK MERRILL A/DirectorNov 05, 2013 Buy$2.0050,000100,000396,432Nov 12, 2013, 04:48 PM
Singh ManishPresident & CEONov 05, 2013 Buy$2.00125,000250,0001,938,500Nov 07, 2013, 08:20 PM
BRISTOL INVESTMENT FUND LTD10% OwnerMay 22, 2013 Option Exercise$3564770.00389,849,5871,389,724,112,249,990399,873,215Jun 04, 2013, 03:17 PM
VOYTICKY DAVID JDirectorMay 22, 2013 Option Exercise$0.015,677,86756,7795,627,867May 30, 2013, 09:19 PM
MCPEAK MERRILL A/Interim President and CEOMay 22, 2013 Option Exercise$0.0121,280,000212,80021,290,000May 30, 2013, 08:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer03/04/2024136,579
Vogt Frederick GInterim CEO & General Counsel03/04/2024194,175
BILINSKY IGORChief Operating Officer03/04/2024123,588
MCPEAK MERRILL ADirector02/20/20242,287,500
Dukes Iain D.Director02/20/2024292,800
Rothbaum Wayne P.Director02/20/202445,749,998
Vogt Frederick GInterim CEO & General Counsel01/16/202454,656
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer01/16/202413,199
BILINSKY IGORChief Operating Officer01/16/202413,199
Vogt Frederick GInterim CEO & General Counsel10/16/202331,598
BILINSKY IGORChief Operating Officer10/16/20234,980
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer10/16/20234,980
MCPEAK MERRILL ADirector09/18/202355,600
Rothbaum Wayne P.Director09/15/202326,500,001
Vogt Frederick GInterim CEO & General Counsel07/14/202368,684
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer07/14/202310,825
BILINSKY IGORChief Operating Officer07/14/202310,825
Vogt Frederick GInterim CEO & General Counsel04/14/202349,920
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer04/14/20237,868
BILINSKY IGORChief Operating Officer04/14/20237,868
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer01/17/202330,080
BILINSKY IGORChief Operating Officer01/17/202330,035
Vogt Frederick GInterim CEO & General Counsel01/17/2023234,316
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer01/03/202367,351
BILINSKY IGORChief Operating Officer01/03/202364,479
Bellemin Jean-MarcChief Financial Officer01/03/202364,479
MCPEAK MERRILL ADirector12/21/202261,500
Rothbaum Wayne P.Director12/02/202265,000,000
MCPEAK MERRILL ADirector11/29/202263,100
Vogt Frederick GInterim CEO & General Counsel11/28/20225,980
MCPEAK MERRILL ADirector11/28/202261,800
Dukes Iain D.Director11/23/202261,000
MCPEAK MERRILL ADirector08/23/2022226,000
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer06/14/202252,634
Bellemin Jean-MarcChief Financial Officer06/14/202272,245
BILINSKY IGORChief Operating Officer06/14/202272,245
MCPEAK MERRILL ADirector05/31/202268,000
MCPEAK MERRILL ADirector05/31/202268,400
Maynard Ryan DDirector05/31/202250,587
WEISER MICHAELDirector05/31/202267,978
Vogt Frederick GInterim CEO & General Counsel06/01/20226,440
Rothbaum Wayne P.Director05/31/20223,384,550
Rothbaum Wayne P.Director06/01/20223,215,500
Fardis MariaPresident and CEO06/01/202062,729
Fardis MariaPresident and CEO05/01/202060,608
Fardis MariaPresident and CEO04/01/202041,742
Fardis MariaPresident and CEO03/02/202047,543
Fardis MariaPresident and CEO02/03/202029,347
Fardis MariaPresident and CEO01/02/202041,674
Fardis MariaPresident and CEO12/02/201942,918
Fardis MariaPresident and CEO11/01/201941,611
Fardis MariaPresident and CEO11/01/201714,257
Fardis MariaPresident and CEO06/03/201923,831
Fardis MariaPresident and CEO05/01/201819,287
Fardis MariaPresident and CEO11/01/201812,708
Fardis MariaPresident and CEO10/01/201715,446
Fardis MariaPresident and CEO05/01/201914,716
Fardis MariaPresident and CEO04/01/201822,325
Fardis MariaPresident and CEO10/01/201814,690
Fardis MariaPresident and CEO09/01/201711,964
Fardis MariaPresident and CEO04/01/201912,919
Fardis MariaPresident and CEO03/01/201823,976
Fardis MariaPresident and CEO10/01/201934,490
Fardis MariaPresident and CEO09/04/201822,589
Fardis MariaPresident and CEO08/01/201711,360
Fardis MariaPresident and CEO03/01/201913,979
Fardis MariaPresident and CEO02/01/201825,163
Fardis MariaPresident and CEO09/03/201932,635
Fardis MariaPresident and CEO08/01/201818,098
Fardis MariaPresident and CEO07/01/201714,656
Fardis MariaPresident and CEO02/01/201914,464
Fardis MariaPresident and CEO01/01/201812,496
Fardis MariaPresident and CEO08/01/201933,250
Fardis MariaPresident and CEO07/01/201816,909
Fardis MariaPresident and CEO06/01/2017782,053
Fardis MariaPresident and CEO01/02/201914,761
Fardis MariaPresident and CEO12/01/201717,547
Fardis MariaPresident and CEO07/01/201932,523
Fardis MariaPresident and CEO06/01/201819,221
Fardis MariaPresident and CEO04/03/2017369,462
Fardis MariaPresident and CEO12/01/201813,791
Dukes Iain D.Director12/18/2018103,796
MCPEAK MERRILL ADirector12/13/201896,273
Rothbaum Wayne P.Director12/06/20182,958,000
Rothbaum Wayne P.Director12/04/20189,496,057
Hillsberg SanfordDirector08/25/2016178,612
Hillsberg SanfordDirector08/24/2016304,800
Hillsberg SanfordDirector08/22/2016491,740
HAWKINS ELMAPresident and CEO02/28/2015215,412
Bender James G.Vice President, Manufacturing09/30/201564,938
Hillsberg SanfordDirector09/04/2015109,440
Hillsberg SanfordDirector09/08/2015117,645
Hillsberg SanfordDirector08/03/2015264,875
Ayer Capital Management, LP10% Owner05/01/201526,752,385
Hillsberg SanfordDirector05/06/2015500,000
BRISTOL INVESTMENT FUND LTD10% Owner11/06/201469,000,000,000
Ayer Capital Management, LPDirector05/22/201327,444,343
MCPEAK MERRILL A/Director11/05/2013100,000
Singh ManishPresident & CEO11/05/2013250,000
BRISTOL INVESTMENT FUND LTD10% Owner05/22/20131,389,724,112,249,990
VOYTICKY DAVID JDirector05/22/201356,779
MCPEAK MERRILL A/Interim President and CEO05/22/2013212,800
Load More Insider Transactions
FUNDS WITH A POSITION IN IOVANCE BIOTHERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.19,071,7560.00395%3.78%Other
GEODE CAPITAL MANAGEMENT, LLC5,037,0980.00428%6.06%Other
ORBIMED ADVISORS LLC4,707,4580.76%No changeOther
BALYASNY ASSET MANAGEMENT L.P.3,926,1590.06%-12.3%Event Driven
CANDRIAM S.C.A.1,727,8220.1%-37.12%Other
PALO ALTO INVESTORS LP2,106,7921.54%NewOther
BALYASNY ASSET MANAGEMENT L.P.1,430,000 (Call)0.01%ExitedEvent Driven
RENAISSANCE TECHNOLOGIES LLC1,226,4000.00951%ExitedOther
VIVO CAPITAL, LLC655,0570.44%No changeOther
FARALLON CAPITAL MANAGEMENT LLC562,0000.02%NewEvent Driven, Value
UBS OCONNOR LLC330,000 (Call)0.06%43.48%Value
UBS OCONNOR LLC104,0590.06%-57%Value
D. E. SHAW & CO., INC.215,1340.00153%469.71%Other
TUDOR INVESTMENT CORP ET AL33,1480.00217%NewEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR IOVANCE BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR IOVANCE BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
4.22%
1Q
12/31/2023
06/30/2023
14.12%
2Q
12/31/2023
03/31/2023
19.88%
3Q
12/31/2023
09/30/2022
62.33%
5Q
12/31/2023
06/30/2022
62.89%
6Q
12/31/2023
03/31/2022
63.05%
7Q
12/31/2023
12/31/2021
63.21%
8Q
12/31/2023
09/30/2021
64.74%
9Q
12/31/2023
06/30/2021
66.62%
10Q
12/31/2023
03/31/2021
73.83%
11Q
12/31/2023
12/31/2020
74.47%
12Q
12/31/2023
09/30/2020
74.88%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
4.22%
1Q
06/30/2023
14.12%
2Q
03/31/2023
19.88%
3Q
09/30/2022
62.33%
5Q
06/30/2022
62.89%
6Q
03/31/2022
63.05%
7Q
12/31/2021
63.21%
8Q
09/30/2021
64.74%
9Q
06/30/2021
66.62%
10Q
03/31/2021
73.83%
11Q
12/31/2020
74.47%
12Q
09/30/2020
74.88%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IOVANCE BIOTHERAPEUTICS INC
LOADING...